Amlodipine for Myocardial Iron in Thalassemia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions
Thalassemia
Interventions
DRUG

Standard Chelation

This will comprise of standard chelation drugs (Deferasirox or Deferoxamine or Combination of Deferoxamine and Deferiprone).The dosage and drug used will depend on ferritin levels and individual requirement, as determined by the treating hematologist and will be in accordance with the Iron chelation guidelines from Pakistan Thalassemia Society.

DRUG

Amlodipine

doses of 0.2 to 0.25 mg/kg/day PO would be given during this trial

Trial Locations (1)

74800

Aga Khan University Hospital, Karachi

All Listed Sponsors
lead

Aga Khan University

OTHER

NCT02065492 - Amlodipine for Myocardial Iron in Thalassemia | Biotech Hunter | Biotech Hunter